Investment Rating - The report maintains a "Buy" rating for Baidu Group-SW (09888.HK) [1] Core Views - Baidu's AI infrastructure capabilities are leading, and the company is expected to see significant commercialization opportunities in its AI business [1][8] - The company's AI cloud business is experiencing rapid growth, driven by strong demand for AI solutions and the advantages of its full-stack AI capabilities [7][8] - Baidu's AI native marketing services are increasingly penetrating traditional advertising, contributing to revenue growth [7][8] - The autonomous driving business is accelerating its globalization, which is anticipated to become a new growth curve for the company [7][8] Financial Forecasts - Total revenue projections for Baidu are as follows: - 2023: 134,598 million - 2024: 133,125 million - 2025: 129,495 million - 2026: 136,140 million - 2027: 142,409 million - Year-on-year growth rates for total revenue are expected to be 8.83% in 2023, -1.09% in 2024, -2.73% in 2025, 5.13% in 2026, and 4.60% in 2027 [1][9] - Net profit attributable to the parent company is forecasted as follows: - 2023: 20,315 million - 2024: 23,760 million - 2025: 21,391 million - 2026: 18,840 million - 2027: 21,682 million - Year-on-year growth rates for net profit are projected at 168.75% in 2023, 16.96% in 2024, -9.97% in 2025, -11.93% in 2026, and 15.08% in 2027 [1][9] - Non-GAAP net profit estimates are as follows: - 2023: 28,747 million - 2024: 27,002 million - 2025: 19,430 million - 2026: 21,714 million - 2027: 24,742 million - Year-on-year growth rates for Non-GAAP net profit are expected to be 39.01% in 2023, -6.07% in 2024, -28.04% in 2025, 11.76% in 2026, and 13.95% in 2027 [1][9] Market Data - The closing price of Baidu's stock is 111.80 HKD, with a market capitalization of approximately 226,525.83 million HKD [5][6] - The price-to-earnings (P/E) ratio is projected to be 13.92 for the current year and 11.91 for the next year [1][9]

Investment Rating - The report upgrades the investment rating of ZTO Express to "Buy" [6] Core Views - In Q3 2025, ZTO Express achieved a revenue of RMB 11.86 billion, a year-on-year increase of 11.1%, with an adjusted net profit of RMB 2.51 billion, reflecting a 5.0% increase year-on-year [1][2] - The growth in express delivery revenue was driven by a 9.8% increase in package volume and a 1.7% increase in average price per package [1] - The company anticipates a total package volume for 2025 to be between 38.2 billion and 38.7 billion, representing a year-on-year growth of 12.3% to 13.8% [2] Summary by Sections Q3 2025 Performance - Adjusted net profit increased by 5.0% year-on-year to RMB 2.51 billion, with a revenue of RMB 11.86 billion [1] - The express delivery business generated RMB 11.02 billion in revenue, up 11.6% year-on-year, supported by a 9.8% increase in package volume [1][2] Operational Data - The company completed 9.57 billion express deliveries in Q3 2025, a 9.8% increase year-on-year, capturing a market share of 19.4% [2] - The number of collection and delivery points exceeded 31,000, with approximately 10,000 owned vehicles [2] Revenue and Cost Analysis - The core revenue per package was RMB 1.22, an increase of RMB 0.02 year-on-year, with cost efficiencies leading to a reduction in sorting and transportation costs [3] - The adjusted net profit per package was RMB 0.26, slightly down from RMB 0.27 in Q3 2024, but improved by RMB 0.05 from Q2 2025 [3] Profit Forecast - ZTO Express is expected to focus on network stability and competitive advantages, with projected net profits for 2025-2027 at RMB 9.62 billion, RMB 11.02 billion, and RMB 12.08 billion respectively [4]

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [2][22]. Core Views - The company plans to issue up to 800 million shares of RMB ordinary shares for listing on the Shenzhen Stock Exchange, which represents 11.52% of the total share capital post-issuance. The funds raised will be used for business development and to supplement working capital [3][4]. - The issuance of A-shares is expected to have a limited dilution effect, and the company has sufficient free cash flow to maintain its dividend per share (DPS) [4][18]. - The garbage incineration industry is entering a mature phase, with a slowdown in capacity release. The national capacity for harmless treatment of municipal solid waste has increased to 1.5226 million tons per day, with incineration accounting for 76.08% [4][12]. - The company’s free cash flow has turned positive, reaching HKD 4.416 billion in 2024, indicating a shift from expansion to refined operations, which may lead to a revaluation in the secondary market [18][25]. Summary by Sections Share Issuance Impact - The proposed issuance of A-shares is expected to increase the total share capital from 6.143 billion to 6.943 billion shares, with a potential upper limit of 7.063 billion shares if the overallotment is exercised. The total dividend amount is projected to increase by 11.3% to HKD 15.97 billion, or by 14.9% to HKD 16.24 billion considering the overallotment [10][4]. Industry Analysis - The number of new garbage incineration projects has decreased significantly, with only 20 new projects in 2024, a reduction of 35 from 2023. The total investment in these projects is estimated at approximately HKD 5.26 billion, down about 80% from HKD 28.77 billion in 2023 [4][15]. Financial Performance - The company’s net profit for 2025 is projected to be HKD 3.532 billion, with a growth rate of 4.6% for the following years. The current price-to-earnings ratio (PE) is estimated at 8.7x for 2025, indicating potential for valuation recovery [22][25]. - The company has maintained a consistent dividend policy, with a projected DPS of HKD 0.23 for 2025, reflecting a commitment to returning value to shareholders [25][22]. Valuation Comparison - The current PE ratio of the company’s H-shares is 9.8x, significantly lower than the average issuance PE of over 20x for A-share listed garbage incineration companies, suggesting room for valuation improvement [18][22].

Investment Rating - The investment rating for the company is "Outperform the Market" [6] Core Insights - The company demonstrated strong performance in Q3, with revenue growth of 15.5% year-on-year, surpassing Bloomberg's expectation of 14.6% [11] - The Non-GAAP net profit increased significantly by 221.2% to 191.56 billion yuan, primarily due to the sale of a stake in Makemytrip [11] - The adjusted EBITDA related to the main business was 63.5 billion yuan, reflecting an 11.7% increase, which also exceeded expectations [11] Revenue Breakdown - The company's accommodation booking revenue reached 80.5 billion yuan, up 18.3%, while transportation ticketing revenue was 63.1 billion yuan, up 11.6% [12] - International platform revenue is expected to grow by 40%, with Trip.com platform hotel and flight bookings increasing over 60% [12] - Domestic revenue is estimated to have grown about 10%, with hotel night stays maintaining a growth rate of 15% [12] Profitability Analysis - The company's gross margin decreased by 0.7 percentage points year-on-year, attributed to structural impacts from the growth of Trip.com [13] - The operating profit margin (OPM) for the first three quarters showed a gradual improvement in the decline rate, indicating operational efficiency [13] - The company is expected to maintain a total revenue growth rate of over 15% despite short-term fluctuations in international travel [14] Financial Forecasts - The company is projected to achieve Non-GAAP net profits of 318 billion yuan in 2025, with a dynamic PE ratio of 11x [14] - Revenue forecasts for the upcoming years are as follows: 61.86 billion yuan in 2025, 71.40 billion yuan in 2026, and 82.24 billion yuan in 2027, reflecting a steady growth trajectory [5][15]

Investment Rating - The investment rating for the company is "Outperform the Market" [6] Core Views - The company has shown a significant recovery in Q3, with revenue exceeding guidance and a notable increase in performance compared to previous quarters. The hotel revenue for Q3 reached approximately 30.6 billion yuan, a year-on-year increase of 17.5% [11] - The company is expected to maintain a stable growth trajectory in Q4, with projected revenue growth of 2-6% and domestic growth of 3-7%. The anticipated growth in franchise revenue is between 17-21% year-on-year [14][15] - The company is focusing on optimizing revenue management and strengthening direct sales channels, which has led to a slight recovery in domestic RevPAR, with a mixed RevPAR of 256 yuan, down only 0.1% year-on-year [12] Summary by Sections Q3 Performance - Q3 revenue was 6.96 billion yuan, up 8.1% year-on-year, surpassing the previous guidance of 2-6%. The net profit attributable to shareholders was 1.47 billion yuan, a 15.4% increase year-on-year [11] - The company’s domestic same-store RevPAR decreased by 4.7% year-on-year, showing a gradual recovery compared to earlier quarters [12] Membership and Revenue Management - The number of members in the company's loyalty program exceeded 300 million, a year-on-year increase of 17.3%. Member bookings increased by 19.7%, accounting for 74% of total room nights [12] - The company has successfully implemented revenue management strategies, resulting in a positive year-on-year growth in average daily rate (ADR) of 0.9% [12] Expansion and Profitability - The company opened 2,038 new stores and closed 483, resulting in a net increase of 1,555 stores. The total number of operating hotels reached 12,600, with a market share estimated at 11% [13] - Franchise revenue and gross operating profit (GOP) increased by 27.4% and 28.6% year-on-year, respectively, while direct store revenue and GOP decreased by 5.5% and 24.7% [13] Future Outlook - The company anticipates a stable or slight increase in domestic RevPAR in Q4, with overall core indicators expected to maintain a healthy development trend [14] - The management expects to exceed the initial target of opening 2,300 new hotels by the end of the year, supported by improved signing and conversion rates [13] Financial Projections - The company has revised its revenue growth projections for 2025-2027, expecting a year-on-year increase of 5.4%, 5.8%, and 6.2%, respectively. Adjusted net profits are projected to be 4.44 billion, 5.17 billion, and 5.78 billion yuan for the same period [15]

Investment Rating - The investment rating for Kuaishou is "Buy" and is maintained [7] Core Insights - Kuaishou's Q3 2025 revenue reached 35.6 billion CNY, representing a year-on-year growth of 14%. The Non-GAAP net profit was 5 billion CNY, up 26% year-on-year. Domestic business operating profit was 5.4 billion CNY, a significant increase of 54% year-on-year, while overseas business incurred an operating loss of 200 million CNY [2][4] Revenue Breakdown - Kuaishou's Q3 2025 online marketing service revenue was 20.1 billion CNY, growing 14% year-on-year, contributing 56.5% to total revenue. The growth was driven by AI-enabled advertising, with ad load and eCPM both improving, leading to a 4-5% increase in domestic advertising revenue. The company also saw a 3% increase in live streaming revenue, totaling 9.6 billion CNY, contributing 26.9% to total revenue. Other services, including e-commerce, generated 5.9 billion CNY, a 41% increase year-on-year, contributing 16.6% to total revenue [8] User Engagement - Kuaishou's content ecosystem continues to thrive, with average daily active users (DAU) reaching 416 million, a 2.1% year-on-year increase, and average monthly active users (MAU) reaching 731 million, up 2.4% year-on-year [8] Profitability Metrics - Kuaishou achieved a gross margin of 54.7% in Q3 2025, with an adjusted net profit margin of 14.0%, reflecting a year-on-year increase of 0.4 percentage points and 1.3 percentage points, respectively. R&D expenses rose by 17.7% to 3.7 billion CNY, primarily due to increased AI investments and employee benefits [8] AI Business Development - The commercialization of Kuaishou's AI, known as Keling, progressed smoothly, generating over 300 million CNY in revenue in Q3 2025, a 20% increase from the previous quarter. The Keling 2.5 Turbo model topped global rankings in video and image generation shortly after its launch [8]

Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage [2][61]. Core Insights - The company has entered the top ten in the industry, emphasizing its long-term value through the "Lighthouse Strategy," which focuses on excellent product quality and advanced living concepts [11]. - The company has shown resilience in sales, with a total sales amount of 70.7 billion yuan in the first half of 2025, reflecting a year-on-year increase of 7.1% [7][28]. - The company maintains a healthy financial structure, with a net debt ratio of 33.4% and an average financing cost of 3.17% as of the first half of 2025 [7][51][54]. - The company is expected to achieve net profits of 4.98 billion yuan, 5.22 billion yuan, and 5.67 billion yuan for the years 2025 to 2027, corresponding to PE ratios of 6.9, 6.6, and 6.1 respectively [7][58][61]. Summary by Sections 1. Company Overview - The company has established itself among the top ten in the industry, supported by the strong backing of Xiamen State-owned Assets [11][14]. - The company’s main revenue source is real estate development, covering over 70 cities nationwide [16][19]. 2. Sales Performance - The company’s sales have shown resilience, with a total sales amount of 707 billion yuan in the first half of 2025, a 7.1% increase year-on-year [7][28]. - The average sales price increased to 26,500 yuan per square meter in the first half of 2025, reflecting a 25% year-on-year growth [7][29][31]. - The sales regions are concentrated in key eastern cities, contributing approximately 70% of total sales [36][37]. 3. Investment and Land Acquisition - The company’s land acquisition amount reached 49.5 billion yuan in the first half of 2025, a 17.9% increase year-on-year [7][38][40]. - The land reserve area increased to 12.71 million square meters, with a total value of 249.6 billion yuan [7][46][49]. 4. Financial Health - The company meets the "three red lines" requirements, with a pre-revenue asset-liability ratio of 58.9% and a cash-to-short-term debt ratio of 3.9 times [7][51][52]. - The average financing cost has decreased from 4.69% in 2021 to 3.17% in the first half of 2025 [54][56]. 5. Profitability Forecast - The company’s total revenue is projected to be 141.85 billion yuan, 130.36 billion yuan, and 126.37 billion yuan for 2025 to 2027, with corresponding growth rates of -0.8%, -8.1%, and -3.1% [57][58]. - The gross profit margin is expected to improve to 14.0%, 14.5%, and 15.0% for the same period [57][58].

Investment Rating - The investment rating for the company is "Outperform the Market" [5][26]. Core Insights - The company reported a revenue increase of 8% year-on-year, with a Non-GAAP net profit of 9.5 billion yuan, reflecting a 27% growth [1][9]. - Deferred revenue grew by 25%, indicating strong future revenue potential [2][26]. - The online gaming segment showed robust performance, with revenue reaching 22.8 billion yuan, a 13% increase year-on-year [2][14]. - The company is focusing on global expansion and the launch of new games, which are expected to drive future growth [2][17]. Financial Performance - In Q3 2025, the company achieved a gross margin of 64.1%, up 1.2 percentage points year-on-year [1][10]. - The total operating expense ratio was 36%, with a sales expense ratio of 15.7%, reflecting increased marketing spending [1][10]. - The forecasted adjusted net profits for 2025-2027 are 39.3 billion, 42.5 billion, and 46.7 billion yuan, respectively [26][28]. Game Performance - Classic games like "Dream of the Red Chamber" continue to attract players, showcasing the company's long-term operational capabilities [2][17]. - The highest concurrent player count for "Dream of the Red Chamber" reached 3.58 million, indicating strong player engagement [2][17]. - New game releases and global launches are anticipated to enhance the company's market presence [2][17]. Other Business Segments - Youdao's revenue increased by 4% year-on-year, with advertising services growing significantly by 51% [3][18]. - Net revenue from NetEase Cloud Music was 2 billion yuan, a 2% decline year-on-year, with a gross margin of 35.4% [3][23].

Investment Rating - The report maintains a "Buy" rating for CSPC Pharmaceutical [8][14] Core Views - CSPC Pharmaceutical reported a revenue of RMB 19.89 billion for the first three quarters of 2025, a decrease of 12.3% year-on-year, with a net profit of RMB 3.51 billion, down 7.1% year-on-year. However, the third quarter showed signs of recovery with a revenue increase of 3.4% year-on-year to RMB 6.62 billion and a net profit increase of 27.2% year-on-year to RMB 964 million, aligning with expectations [5][10] - The company's gross margin decreased by 4.9 percentage points year-on-year to 65.6% in the first three quarters of 2025, with the sales contribution from finished drugs dropping from 82.3% to 77.7% [10][11] - The report highlights a significant decline in oncology product sales, which fell by 56.8% year-on-year to RMB 1.65 billion, representing only 10.7% of total finished drug sales [11] - CSPC has made progress in its innovative pipeline, with 28 key products in pivotal clinical trials and an increase in R&D expenses by 7.9% year-on-year to RMB 4.19 billion, reflecting a commitment to innovation [8][13] Financial Summary - For 2025, the company expects a revenue of RMB 26.785 billion, a decrease of 7.67% year-on-year, and a net profit of RMB 4.559 billion, with an EPS forecast adjusted down to RMB 0.40 [9][14] - The report projects a target price adjustment from HKD 12.7 to HKD 9.7, indicating a potential upside of 31% [14]

Investment Rating - The report maintains a "Buy" rating for CSPC Pharmaceutical [1][14] Core Views - The company reported a 12.3% year-on-year decline in revenue for the first three quarters of 2025, totaling RMB 19.89 billion, while net profit decreased by 7.1% to RMB 3.51 billion. However, in the third quarter, revenue grew by 3.4% year-on-year to RMB 6.62 billion, and net profit increased by 27.2% to RMB 964 million, aligning with expectations [4][10] - The gross margin decreased by 4.9 percentage points year-on-year to 65.6%, with the sales contribution from finished drugs dropping from 82.3% in the first three quarters of 2024 to 77.7% in 2025 [4][10] - The company has a robust pipeline with 28 key products in pivotal clinical trials and a significant increase in R&D expenses, which rose by 7.9% year-on-year to RMB 4.19 billion, representing 21.0% of revenue [7][13] Financial Performance - For the first three quarters of 2025, finished drug sales fell by 17.3% year-on-year to RMB 15.45 billion, but third-quarter sales returned to growth at RMB 5.20 billion, up 1.6% year-on-year [5][11] - The oncology product sales saw a significant decline of 56.8% year-on-year to RMB 1.65 billion, now representing 10.7% of total finished drug sales [5][11] - The API segment experienced a 22.3% year-on-year increase in vitamin C revenue to RMB 1.79 billion, while antibiotic API revenue slightly declined by 3.7% due to price drops [5][11] Pipeline Development - The company is advancing multiple trials for SYS6010 (EGFR ADC), which has received Fast Track Designation from the FDA and Breakthrough Therapy Designation from the NMPA, with data readouts expected in 2026 [6][12] - The innovative pipeline includes 28 products in phase II/III trials, nine in phase II, and approximately 40 in phase I, covering both oncology and non-oncology areas [7][13] Earnings Forecast - The earnings per share (EPS) forecast for 2025 has been adjusted down from RMB 0.46 to RMB 0.40, with target prices revised from HK$12.7 to HK$9.7, indicating a potential upside of 31% [14]